Back to search
FDAFDA · Food and drugs·Recall number D-0235-2024

Atropine Sulfate Injection, USP 1 mg/10 mL (0.1 mg/mL), Lifeshield, Glass ABBOJECT Unit of Use Syringe, Rx Only, 10 mL Syringe per Carton, Hospira, Inc., Lake FOrest, IL 60045, NDC 0409-4911-11 (carton), 0409-4911-34 (case).

Published January 24, 2024 · Recall initiated: December 21, 2023

Summary

FDA records drug Class I recall D-0235-2024, published January 24, 2024 and initiated December 21, 2023. Recalling firm: Pfizer Inc.; Status: Ongoing; Reported quantity: 24400 Cartons; Lot: Lot GY2496, Exp 02/01/2025. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter; identified as glass

What to do

Voluntary: Firm initiated · Letter

Get an email if ATROPINE SULFATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ATROPINE SULFATE
Manufacturer
Pfizer Inc.
Distributor
Nationwide in the USA and Puerto Rico.
Lot
Lot GY2496, Exp 02/01/2025
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Atropine Sulfate Injection, USP 1 mg/10 mL (0.1 mg/mL), Lifeshield, Glass ABBOJECT Unit of Use Syringe, Rx Only, 10 mL Syringe per Carton, Hospira, Inc., Lake FOrest, IL 60045, NDC 0409-4911-11 (carton), 0409-4911-34 (case). recalled?

Yes. FDA published recall D-0235-2024 on January 24, 2024. Reported hazard: Presence of Particulate Matter; identified as glass

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ATROPINE SULFATE.